Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chr. Hansen Holding Director's Dealing 2016

Nov 7, 2016

3357_rns_2016-11-07_727dd57b-ca90-45a8-b728-1eac8fc217e5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

CHR HANSEN
Improving food & health
COMPANY ANNOUNCEMENT
NO.18/2016
7 November 2016

Long-term incentive program. Managers' transactions in Chr. Hansen Holding A/S

Pursuant to the Company's overall guidelines for incentive-based remuneration and the matching shares program, the Board of Directors has today made grants to the Company's Executive Board and certain other senior employees.

In accordance with the program, the participants are required to acquire a number of existing shares in Chr. Hansen Holding A/S (investment shares) and retain ownership of such shares for a predefined holding period of three (3) years (the holding period). Upon expiration of the holding period and subject to fulfillment of certain predefined performance targets, the participants will be entitled to receive up to five and a half (5.5) additional shares in Chr. Hansen Holding A/S (matching shares) per investment share against no consideration.

The defined performance targets are related to the development of organic growth, EBIT as well as the Total Shareholder Return defined as the relative return compared to a predefined group of similar companies.

The total number of matching shares which the participants will be able to receive based on the grants made is 50,501. The theoretical market value of the grants amounts to DKK 11,618,510, based on likely level of achievement of the performance targets, i.e. three and a half (3.5) matching shares per investment share with three (3) years of estimated dividends of 1.5% per year deducted.

Chr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in Chr. Hansen Holding A/S made by persons discharging managerial responsibilities in Chr. Hansen Holding A/S and/or persons closely related with them.

For further information please contact:

Anders Mohr Christensen, Senior Director, Investor Relations, Tel: +45 4574 7618
Camilla Lercke, Head of Media Relations, Tlf: +45 4574 7474

Managers' transactions

Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970, Hoersholm
Denmark

Tel. +45 45 74 74 74
www.chr-hansen.com
CVR-no: 28318677

Page 1/4


Managers' transactions
Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970, Hoersholm
Denmark
Tel. +45 45 74 74 74
www.chr-hansen.com
CVR-no: 28318677
Page 2/4

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Cornelis (Cees) de Jong
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Chr. Hansen Holding A/S
b) LEI N/A
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Matching shares
DK 0060227585
b) Nature of the transaction Grant of a right to receive matching shares in Chr. Hansen Holding A/S under the matching shares program
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 0.00 2,095
d) Aggregated information
— Aggregated volume
— Price
e) Date of the transaction 7 November 2016
f) Place of the transaction Outside the trading venue

Managers' transactions
Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970, Hoersholm
Denmark
Tel. +45 45 74 74 74
www.chr-hansen.com
CVR-no: 28318677
Page 3/4

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Knud Vindfeldt
2 Reason for the notification
a) Position/status Chief Operating Officer and Deputy CEO
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Chr. Hansen Holding A/S
b) LEI N/A
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Matching shares
DK 0060227585
b) Nature of the transaction Grant of a right to receive matching shares in Chr. Hansen Holding A/S under the matching shares program
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 0.00 1,101
d) Aggregated information
— Aggregated volume
— Price
e) Date of the transaction 7 November 2016
f) Place of the transaction Outside the trading venue

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Søren Westh Lonning
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Chr. Hansen Holding A/S
b) LEI N/A
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Matching shares
DK 0060227585
b) Nature of the transaction Grant of a right to receive matching shares in Chr. Hansen Holding A/S under the matching shares program
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 0.00 806
d) Aggregated information
— Aggregated volume
— Price
e) Date of the transaction 7 November 2016
f) Place of the transaction Outside the trading venue

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2015/16 financial year was EUR 949 million. The company has more than 2,700 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen. For further information, please visit www.chr-hansen.com.

Managers' transactions

Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970, Hoersholm
Denmark

Tel. +45 45 74 74 74
www.chr-hansen.com
CVR-no: 28318677